CAPITAL GROUP INTL FOCUS EQT - SHS CREATION UNI (CGXU)

CUSIP: 14019W109

Q4 2025 13F Holders as of 31 Dec 2025

Share change
+8,785,250
SEC-reported price per share
$29.55
Number of holders
333
Value change
+$259,439,274
Number of buys
225
Number of sells
73

Security key

14019W109

Report period

Q4 2025

Institutions

333

Top holders

10

Ownership snapshot

Top reported holders of CGXU - CAPITAL GROUP INTL FOCUS EQT - SHS CREATION UNI (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
333
Shares
119,424,975
Rows available
333
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
298
Q4 2025 holders
333
Holder diff
35
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .